Company Filing History:
Years Active: 2002-2009
Title: The Innovative Contributions of Kurt Schellhaas
Introduction: Kurt Schellhaas, based in Ludwigshafen, Germany, is a notable inventor in the field of medicinal chemistry. With two patents to his name, Schellhaas has focused his efforts on developing innovative therapeutic compounds. His inventions demonstrate a strong commitment to addressing significant health concerns.
Latest Patents: Some of Kurt Schellhaas's latest patents include "3-Substituted 3,4-dihydro-thieno[2,3-d]pyrimidin-4-one derivatives, production and use thereof." This invention outlines a range of 3,4-dihydrothieno[2,3-d]pyrimidin-4-one derivatives, focusing particularly on those substituted at position 3 by 5-membered heteroaryl groups. These compounds, with the potential for various therapeutic applications, provide a foundation for the treatment of conditions such as depression. His work also emphasizes the preparation and utilization of pyrimidine derivatives aimed at preventing and treating cerebral ischemia.
Career Highlights: Throughout his career, Kurt Schellhaas has made significant contributions while working at renowned companies such as Abbott GmbH & Co. KG and BASF Aktiengesellschaft. His experience in these organizations has enriched his understanding and capability in drug development and innovation in the pharmaceutical sector.
Collaborations: Kurt has collaborated with several prominent professionals, including Gerd Steiner and Margaretha Bakker. These collaborations have played a crucial role in reinforcing the impact of his inventions and expanding their potential applications.
Conclusion: Kurt Schellhaas stands out as a dedicated inventor whose innovative work in medicinal chemistry continues to contribute valuable advancements in therapeutic solutions. His patents not only reflect his ingenuity but also represent significant strides toward improving healthcare outcomes for various conditions.